MAPT and brain injury: In a rodent model of repetitive mild traumatic brain injury (rmTBI), psilocybin administration reduced phosphorylated Tau (PHF-1 epitope) levels in the soluble fraction and showed a downward trend in insoluble aggregated Tau [15].